In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
Polymyxin B sulfate and trimethoprim (Polytrim) is an antibacterial eye drop prescribed to treat bacterial conjunctiivitis and blepharoconjunctivitis of the eyes. Side effects, drug interactions, pregnancy safety, dosage, and storage information should be reivewed prior to using this medication.